|
Indian Pediatr 2017;54: 689 |
 |
Severe Complications of Mumps
|
* Jenish Rajma and
# AC Arun
Department of *Pediatrics and #Medicine
Velammal Medical College Hospital and Research Institute, Madurai,
Tamilnadu, India.
Email: [email protected]
|
Mumps is a common childhood infection caused by the mumps virus. We
present a case series of three school-going children who had mumps
parotitis following which they developed severe CNS and renal
complications necessitating intensive care management.
An 11-year-old boy, first born of non consanguinous
marriage and immunized according to national schedule along with one
dose of MMR at 15 months of age, was admitted with complains of
bilateral parotid swelling 2 weeks ago, associated with low grade fever
that settled over next 5 days. Two days later, child developed
headache with projectile vomiting and poor oral intake followed by
one episode of generalized tonic clonic seizure and postictal vision loss. On
examination, child had altered sensorium, bradycardia, hypertension,
neck rigidity and papilledema. We suspected mumps meningo-encephalitis
with raised intracranial pressure; magnetic resonance imaging (MRI) of
brain was suggestive of diffuse leptomeningeal enhancement with gyral
swelling and subcortical white matter edema. Child was managed in
intensive care unit with ventilation and medication to reduce
intracranial pressure. Three days later, he developed gross hematuria.
Urine examination was suggestive of proteinuria. C3 was low, ASO and ANA
were negative, and IgM mumps was strongly positive.
One month later, we saw a similar presentation in an
11-year-old girl, who had not received any prior MMR vaccine. She
presented to us with secondary generalized left focal seizures following
an episode of mumps like illness. CSF study showed 400 cells (mostly
lymphocytes) with normal protein and sugar. Neuroimaging was suggestive
of encephalitis with hyperintensities in temporoparietal cortical
regions. She was treated in intensive care for two days with supportive
care, including antiepileptics and measures to reduce raised
intracranial pressure. From Day 9 of illness, child developed gross
hematuria associated with persistent hypertension. Urinanalysis showed
plenty of red blood cells with 1+ proteinuria and normal renal
functions. IgM mumps serology was positive. Child was managed as
glomerulonephritis with diuretics and anti-hypertensives.
An 8-year-old girl, developmentally normal and
vaccinated for age, presented to us with seizures, hemiparesis and
aphasia 5 days after onset of parotid swelling. On examination at the
time of admission, child was conscious, and had motor aphasia, facial
palsy and left sided hemiparesis. Bladder and bowel incontinence was
present. Meningeal signs were absent. She was diagnosed as vasculitic
stroke with acute infarct in right middle carotid artery territory.
Workup for tuberculosis was negative. IgM mumps serology was strongly
positive. Procoagulant workup revealed protein S deficiency, which was
considered secondary to infection.
CDC recommends children to be given two doses of MMR
vaccine, starting with the first dose at 12 through 15 months of age,
and the second dose at 4 through 6 years of age. But it is still an
optional vaccine in India, not yet included in the national immunization
schedule. Recent outbreaks of mumps have been described in developed
countries since 2005, and are caused by incomplete protection following
vaccination, waning of immunity, and intensive crowding. Mumps currently
affects mainly people who were vaccinated more than 10 years ago [1,2].
In India, MMR vaccine is an important component of
the IAP-ACVIP schedule and being given at 9 month and 15-18 months [3].
Inclusion of MMR vaccine in our national immunization schedule is the
need of the hour. MMR vaccine is a very effective way to prevent
measles, mumps and rubella, among which both mumps and measles have
serious CNS complications. Hence it is essential to give a complete
coverage for these infections through immunization, both in toddlers and
school-going children.
References
1. Albertson JP, Clegg WJ, Reid HD, Arbise BS, Pryde
J, Vaid A, et al. Mumps outbreak at a University and
recommendation for a third dose of measles-mumps-rubella vaccine –
Illinois, 2015–2016. MMWR. 2016;65:731-4.
2. Kutty PK, McLean HQ, Lawler J, Schulte C, Hudson
JM, Blog D, et al. Risk factors for transmission of mumps in a
highly vaccinated population in Orange County, NY, 2009-2010. Pediatr
Infect Dis J. 2014;33:121-5.
3. Vashishtha VM, Choudhury P, Kalra A, Bose A,
Thacker N, Yewale VN, et al.; Indian Academy of Pediatrics.
Indian Academy of Pediatrics (IAP) recommended immunization schedule for
children aged 0 through 18 years – India, 2014 and updates on
immunization. Indian Pediatr. 2014;51: 785-800.
|
|
 |
|